Increased proportion of HLA-class-I-specific natural killer cell receptors (CD94) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation

被引:12
作者
Tanaka, J
Tutumi, Y
Zhang, L
Mori, A
Kahata, K
Toyoshima, N
Ohta, S
Kobayashi, S
Hashino, S
Asaka, M
Imamura, M
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Hematol & Oncol, Kita Ku, Sapporo, Hokkaido 0608638, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Internal Med 3, Sapporo, Hokkaido, Japan
[3] Hokkaido Univ, Grad Sch Med, Dept Transfus Med 3, Sapporo, Hokkaido, Japan
关键词
bone marrow transplantation; CD94; graft versus host disease; graft versus leukemia; killer cell inhibitory receptor;
D O I
10.1159/000046540
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the present study, we investigated the inhibitory natural killer cell receptor (NKR) expression of CD94/NKG2A on PBMC after allogeneic bone marrow transplantation (BMI). The proportion of CD94 expression on PBMC was higher in patients without chronic graft-versus-host disease (cGVHD) and also in cGVHD patients with good response to conventional immunosuppressive therapy than in cGVHD patients with poor response. Also, the proportions of CD94+/CD3+ cells and CD94+/CD8+ cells were higher in cGVHD patients showing good response. In addition, the proportion of NKG2A-expressing cells was higher in patients without cGVHD than in patients with cGVHD. Therefore, chronic allostimulation after allo-BMT may augment the proportion of CD94/NKG2A-positive cells, and these cells may play some role in the regulation of alloresponse in some patients, Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:89 / 91
页数:3
相关论文
共 16 条
[1]   Natural killer (NK)-cell function and antileukemic activity of a large population of CD3(+)/CD8(+) T cells expressing NK receptors for major histocompatibility complex class I after ''three-loci'' HLA-incompatible bone marrow transplantation [J].
Albi, N ;
Ruggeri, L ;
Aversa, F ;
Merigiola, C ;
Tosti, A ;
Tognellini, R ;
Grossi, CE ;
Martelli, MF ;
Velardi, A .
BLOOD, 1996, 87 (09) :3993-4000
[2]  
Bakker ABH, 1998, J IMMUNOL, V160, P5239
[3]   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[4]   Modulation of T-cell functions in KIR2DL3 (CD158b) transgenic mice [J].
Cambiaggi, A ;
Darche, S ;
Guia, S ;
Kourilsky, P ;
Abastado, JP ;
Vivier, E .
BLOOD, 1999, 94 (07) :2396-2402
[5]   Natural killer cell acceptance of H2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor (CD158b) [J].
Cambiaggi, A ;
Verthuy, C ;
Naquet, P ;
Romagne, F ;
Ferrier, P ;
Biassoni, R ;
Moretta, A ;
Moretta, L ;
Vivier, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) :8088-8092
[6]  
Guerra N, 1999, EUR CYTOKINE NETW, V10, P357
[7]   NK cell receptors [J].
Lanier, LL .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :359-393
[8]   MHC-RECOGNIZING RECEPTORS - THEYRE NOT JUST FOR T-CELLS ANYMORE [J].
LEIBSON, PJ .
IMMUNITY, 1995, 3 (01) :5-8
[9]   Inhibitory MHC class I receptors on NK and T cells: A standard nomenclature [J].
Long, EO ;
Colonna, M ;
Lanier, LL .
IMMUNOLOGY TODAY, 1996, 17 (02) :100-100
[10]   Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses [J].
Mingari, MC ;
Moretta, A ;
Moretta, L .
IMMUNOLOGY TODAY, 1998, 19 (04) :153-157